LJ-2698, an Adenosine A3 Receptor Antagonist, Alleviates Elastase-Induced Pulmonary Emphysema in Mice-Reference-Cited by-同舟云学术

LJ-2698, an Adenosine A3 Receptor Antagonist, Alleviates Elastase-Induced Pulmonary Emphysema in Mice

Published:2020-05-01 Issue:3 Volume:28 Page:250-258
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomolecules & Therapeutics

Author:

Boo Hye-Jin¹,Park So Jung¹,Noh Myungkyung¹,Min Hye-Young²,Jeong Lak Shin¹,Lee Ho-Young¹²

Affiliation:

1. College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Republic of Korea

2. Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea

Funder

National Research Foundation of Korea

Ministry of Science and ICT

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2020/028/BT028-03-05.pdf

Reference49 articles.

1. The crucial roles of inflammatory mediators in inflammation: A review

2. Chronic obstructive pulmonary disease

3. The A3Adenosine Receptor: History and Perspectives

4. PPARγ Activation Primes Human Monocytes into Alternative M2 Macrophages with Anti-inflammatory Properties

5. Emerging anti-inflammatory strategies for COPD

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hypnotic effect of AR-001 through adenosine A1 receptor;European Journal of Pharmacology;2024-10

2. Mechanisms, Pathophysiology and Currently Proposed Treatments of Chronic Obstructive Pulmonary Disease;Pharmaceuticals;2021-09-26

3. Chronic Obstructive Pulmonary Disease: Epidemiology, Biomarkers, and Paving the Way to Lung Cancer;Journal of Clinical Medicine;2021-06-29